Background & objectives:
The spread of drug-resistant
Plasmodium falciparum
(
Pf
) poses a serious threat to the control and elimination of malaria. The objective of this study was to detect the molecular biomarkers of antimalarial drug resistance in
Pf
in patients visiting a tertiary care hospital in Assam.
Methods:
Malaria was first detected in fever cases using microscopy and a rapid diagnostic test (RDT), and then confirmed using PCR.
Pf
chloroquine resistance transporter (
Pfcrt
),
Pf
multidrug resistance-1 (
Pfmdr-1
), and single-nucleotide polymorphisms linked to delayed parasite clearance after treatment with artemisinin
MAL 10
-688956 and
MAL 13
-1718319 and
Kelch-13
propeller (
PfK-13
) genes were evaluated by PCR-restriction fragment length polymorphism (RFLP).
Results:
Sixty nine cases of malaria were found among 300 cases of fever. Of these, 54 were positive for
Pf
, 47 of which were confirmed by PCR.
Pfcrt
-K76T mutation was seen in 96.6 per cent and
Pfmdr1
-N86Y mutation in 84.2 per cent of cases. Mutation was not detected in
MAL10
and
MAL13
genes. Sequence analysis of
Kelch-13
gene showed the presence of a novel mutation at amino acid position 675. Statistically, no significant association was found between the molecular biomarkers and demographic profile, clinical presentation and outcome of the cases.
Interpretation & conclusions:
Molecular surveillance is essential to assess the therapeutic efficacy of the drugs against circulating
Pf
isolates in Assam which are found to be highly resistant to CQ. The role of the new mutation found in the
Kelch-13
gene in the development of artemisinin resistance in Assam needs to be thoroughly monitored in future research.